MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Urogenital dysfunction"

  • 2018 International Congress

    Urinary symptoms and Urodynamic findings in patients with SCAs and DRPLA

    M. Jang, A. Kim, B. Jeon, H. Kim (Jeollabuk-do, Republic of Korea)

    Objective: To investigate the lower urinary tract symptoms (LUTS) and findings of the urodynamic study (UDS) in patients with spinocerebellar ataxia (SCA) and dentatorubral pallidoluysian…
  • 2018 International Congress

    Single-centre open label exploratory phase IIb pilot study of exogenous oral Melatonin for the treatment of Nocturia in adults with Parkinson’s disease

    A. Batla, U. Uchiyama, S. Simeoni, C. Melbourne, M. Baldwin, L. DeMin, G. Gonzales, C. Haslam, M. Pakzad, S. Islam, S. Eriksson, K. Bhatia, J. Panicker (London, United Kingdom)

    Objective: To evaluate the effect of melatonin on nocturia. Background: Nocturia is one of the commonest non motor symptoms in Parkinsons’ disease (PD), and has…
  • 2017 International Congress

    Assessment of Autonomic Dysfunction in Parkinson’s Disease

    K. Karbozova, , (Bishkek, Kyrgyzstan)

    Objective: Assessment of autonomic dysfunction in patients with Parkinson's disease and further comparison with patients without autonomic symptoms Background: A frequent disabling complication of Parkinson’s…
  • 2017 International Congress

    Abnormal melatonin secretion rhythm and nocturnal polyuria in patients with Parkinson’s disease

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, A. Numao, H. Fujita, Y. Watanabe, T. Matsubara, M. Miyamoto, K. Kaga, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)

    Objective: To evaluate the association between melatonin secretion rhythm and nocturnal polyuria, and the pathophysiology of nocturnal polyuria in PD. Background: Patients with PD have…
  • 2017 International Congress

    Effect of Urinary Dysfunction on Depression and Anxiety Development in Parkinson’s Disease

    E. Benli, F. Ozer, N. Helvaci Yilmaz, T. Ozcan, O. Arici Duz (Ordu, Turkey)

    Objective: To investigate the relationship between urinary dysfunction (UD) and anxiety and depression in Parkinson's Disease (PD).    Background: Urinary dysfunction is one of the…
  • 2017 International Congress

    Parkinson’s Disease and Urogenital Dysfunction

    N. Sözer, M. Yenice, H. Erdogan, E. Demir, I. Yiğitbaşı, V. Tuğcu, V. Yayla (Istanbul, Turkey)

    Objective: The aim of this study is to identify  the involvement of urogenital functions in PD.  Background: Urogenital dysfunction could occur  in neurological diseases due to central…
  • 2016 International Congress

    Detrusor overactivity is associated with frontal dysfunction in patients with Parkinson’s disease?

    T. Uchiyama, T. Yamamoto, K. Suzuki, T. Kadowaki, Y. Watanabe, K. Hashimoto, T. Shingo, K. Kaga, C. Shibata-Yamaguchi, T. Yamanishi, R. Sakakibara, S. Kuwabara, K. Hirata (Tochigi, Japan)

    Objective: To present the prefrontal cortex activity in patients with Parkinson's disease (PD) and evaluated the association between prefrontal cortex and lower urinary tract dysfunction…
  • 2016 International Congress

    Parasacral effects of electrical stimulation on lower urinary tract symptoms and constipation in patients with Parkinson’s disease: Preliminary data

    I.V. Brandi, L.F. Silva, A.M. Lanzarini, A.F.A. Musengante (Salvador, Brazil)

    Objective: To evaluate the effectiveness of parasacral electrostimulation in symptoms of lower urinary tract and constipation, besides the urodynamic parameters in patients with Parkinson's disease.…
  • 2016 International Congress

    Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry

    L. Wang, N. Prinz, A. Marcus, K. Laubner, A. Zimmerman, S. Zlamal-Fortunat, M. Sharma, R. Holl (Tübingen, Germany)

    Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…
  • 2016 International Congress

    α-synuclein CSF levels correlate with urinary dysfunction in early de novo Parkinson’s disease patients

    G. Pagano, F. Niccolini, M. Politis (London, United Kingdom)

    Objective: To explore the association between levels of α-synuclein burden and urinary dysfunction in early de novo (untreated) Parkinson's disease (PD) patients. Background: Urinary dysfunction…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley